Literature DB >> 10080440

Radiofrequency ablation of "class IC atrial flutter" in patients with resistant atrial fibrillation.

A Nabar1, L M Rodriguez, C Timmermans, J L Smeets, H J Wellens.   

Abstract

In some patients with atrial fibrillation, atrial flutter develops after administration of class IC antiarrhythmic drugs, the so-called class IC atrial flutter. Radiofrequency ablation of the right atrial isthmus results in clinical improvement in 85% of patients and provides an alternative management strategy for a subset of patients with therapy-resistant atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10080440     DOI: 10.1016/s0002-9149(98)00992-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

Review 1.  New devices and hybrid therapies and new devices for treatment of atrial fibrillation.

Authors:  R B Krol; S Saksena; A Prakash
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

2.  Giant P waves after pharmacological cardioversion of atrial fibrillation.

Authors:  Girolamo Catapano-Minotti; Andrea Corsonello; Raffaele Antonelli Incalzi
Journal:  Intern Emerg Med       Date:  2008-12-03       Impact factor: 3.397

3.  Pharmacological and ablative hybrid therapy of atrial fibrillation. Long-term effect on quality of life and arrhythmia-related symptoms.

Authors:  H Bielik; J Schrickel; N Shlevkov; A Yang; J O Schwab; A Bitzen; B Lüderitz; T Lewalter
Journal:  Z Kardiol       Date:  2005-09

4.  Class IC antiarrhythmic drug induced atrial flutter: electrocardiographic and electrophysiological findings and their importance for long term outcome after right atrial isthmus ablation.

Authors:  A Nabar; L M Rodriguez; C Timmermans; R van Mechelen; H J Wellens
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

Review 5.  Management of atrial flutter.

Authors:  E Kongsgaard; H Aass
Journal:  Curr Cardiol Rep       Date:  2000-07       Impact factor: 2.931

6.  Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation.

Authors:  Atul Prakash; Sanjeev Saksena; Ryszard B Krol; Artur Filipecki; George Philip
Journal:  J Interv Card Electrophysiol       Date:  2002-06       Impact factor: 1.900

Review 7.  Interactions of antiarrhythmic drugs with implantable defibrillator therapy for atrial and ventricular tachyarrhythmias.

Authors:  R B Krol; S Saksena; A Prakash
Journal:  Curr Cardiol Rep       Date:  1999-11       Impact factor: 2.931

8.  Hybrid pharmacological and ablative therapy for the management of symptomatic atrial fibrillation.

Authors:  G P Kimman; T Szili-Torok; M Nieuwdorp; D A M J Theuns; M Scholten; L Jordaens
Journal:  Neth Heart J       Date:  2002-01       Impact factor: 2.380

9.  Can atrial fibrillation with a coarse electrocardiographic appearance be treated with catheter ablation of the tricuspid valve-inferior vena cava isthmus? Results of a multicentre randomised controlled trial.

Authors:  Dhiraj Gupta; Mark J Earley; Guy A Haywood; Laura Richmond; Melissa Fitzgerald; Pipin Kojodjojo; Simon C Sporton; Nicholas S Peters; Paul Broadhurst; Richard J Schilling
Journal:  Heart       Date:  2006-11-29       Impact factor: 5.994

Review 10.  Flecainide: Current status and perspectives in arrhythmia management.

Authors:  George K Andrikopoulos; Sokratis Pastromas; Stylianos Tzeis
Journal:  World J Cardiol       Date:  2015-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.